Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Cancer Letters|February 14, 2013
IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancerConnie Bitelman, Rive Sarfstein, Menahem Sarig, et al.Endocrine-Related Cancer|April 20, 2016
Identification of signaling pathways associated with cancer protection in Laron syndromeLena Lapkina-Gendler, Itai Rotem, Metsada Pasmanik-Chor, et al.Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 7, 2017
Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidenceLina Somri, Rive Sarfstein, Lena Lapkina-Gendler, et al.Cells|July 2, 2021
The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling PathwayRand Shibel, Rive Sarfstein, Karthik Nagaraj, et al.The Journal of Endocrinology|December 16, 2006
Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1Sharon Maor, Doris Mayer, Ronit I Yarden, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2012
BRCA1 is expressed in uterine serous carcinoma (USC) and controls insulin-like growth factor I receptor (IGF-IR) gene expression in USC cell linesKeren Amichay, Debora Kidron, Zohar Attias-Geva, et al.European Journal of Cancer (Oxford, England : 1990)|October 29, 2011
p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapyZohar Attias-Geva, Itay Bentov, Dvora Kidron, et al.Proceedings of the National Academy of Sciences of the United States of America|January 18, 2018
Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 actionKarthik Nagaraj, Lena Lapkina-Gendler, Rive Sarfstein, et al.Oncotarget|July 20, 2019
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancerLaris Achlaug, Rive Sarfstein, Karthik Nagaraj, et al.Journal of Molecular Endocrinology|August 10, 2005
The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cellsNaama Reizner, Sharon Maor, Rive Sarfstein, et al.Pageof 5